Medicare will save approximately $12 billion, or 44%, on 15 high-cost medications as a result of the second round of the program’s drug price negotiations, the Trump administration announced Tuesday ...

Medicare’s 2026 drug price negotiations under the Inflation Reduction Act aim to lower the cost of expensive medications, ...

The IRA requires health plans serving the Part D market to cover all negotiated drugs, and it has been predicted that CMS ...

On Tuesday, the Trump administration celebrated drug price cuts it had secured through a Democrat-created program — despite Republicans’ longstanding antipathy of the policy.

Medicare announced 15 lower drugs after a second round of negotiations with pharmaceutical companies. The drugs include ...

The White House on Tuesday confirmed that all drugmakers agreed to engage in the price talks. "Today I can announce that the manufacturers of ten drugs are coming to the negotiating table to lower ...

Pharmacies will be the canary in the coal mine for the Medicare Drug Price Negotiation Program, writes Sujith Ramachandran.

The pharma industry has called the IRA “price setting” and argues that the negotiations have not cut out-of-pocket costs for ...

The new prices were made possible by the Medicare negotiation program created under the Biden administration's Inflation Reduction Act.

Topping the list are Novo Nordisk's blockbuster diabetes injection Ozempic, weight loss shot Wegovy and diabetes pill Rybelsus, which are considered one product in the talks since they all share the ...

The Centers for Medicare and Medicaid Services has announced the expected savings from a second round of Medicare drug price negotiations. There is a net savings of 44%, or $12 billion, from ...